Valliance Asset Management Ltd Makes New Investment in Astera Labs, Inc. $ALAB

Valliance Asset Management Ltd purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 337,150 shares of the company’s stock, valued at approximately $162,850,000. Astera Labs accounts for approximately 18.8% of Valliance Asset Management Ltd’s holdings, making the stock its 3rd biggest holding.

Other hedge funds also recently modified their holdings of the company. Nykredit A S bought a new stake in shares of Astera Labs in the 2nd quarter valued at about $23,699,000. EMC Capital Management acquired a new position in shares of Astera Labs in the second quarter valued at about $97,000. B. Metzler seel. Sohn & Co. AG increased its position in Astera Labs by 18.1% during the second quarter. B. Metzler seel. Sohn & Co. AG now owns 3,424 shares of the company’s stock worth $1,654,000 after acquiring an additional 524 shares during the period. Secure Asset Management LLC acquired a new stake in shares of Astera Labs in the second quarter valued at approximately $226,000. Finally, Vanguard Capital Wealth Advisors acquired a new stake in shares of Astera Labs during the 2nd quarter worth approximately $290,000. Institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

Shares of ALAB stock traded down $7.89 on Friday, hitting $282.63. 1,756,522 shares of the stock traded hands, compared to its average volume of 5,446,093. The stock has a market capitalization of $49.03 billion, a PE ratio of 139.92 and a beta of 3.84. The firm’s 50-day moving average price is $354.34 and its two-hundred day moving average price is $244.64. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same quarter in the previous year, the business posted $0.44 earnings per share. The business’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 136,974 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the sale, the director directly owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of Astera Labs stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the sale, the director owned 75,688 shares in the company, valued at $26,882,106.96. This represents a 11.67% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 419,244 shares of company stock worth $163,135,169 over the last three months. 10.40% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

ALAB has been the subject of several analyst reports. Morgan Stanley raised their price target on shares of Astera Labs to $335.00 and gave the company an “overweight” rating in a research note on Monday, August 3rd. Evercore reissued an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. UBS Group restated a “neutral” rating and issued a $425.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Royal Bank Of Canada upped their price objective on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Finally, Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price target on the stock in a report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $333.00.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.